Margherita Pizzato, Valerie McCormack, Laure Dossus, Umaima Al-Alem, Cyrille Delpierre, Sebastien Lamy, Alessandra Macciotta, Fulvio Ricceri, Lene Mellemkjær, Anne Tjønneland, Christina C Dahm, Christian S Antoniussen, Pascal Guénel, Agnès Fournier, Pauline Frenoy, Matthias B Schulze, Rudolf Kaaks, Renée Turzanski Fortner, Pietro Ferrari, Valeria Pala, Salvatore Panico, Rosario Tumino, Giovanna Masala, Karina Standahl Olsen, Inger Torhild Gram, Tonje Braaten, Carlota Castro, Pilar Amiano Etxezarreta, Amaia Atxega, José María Huerta, Maria-José Sánchez, Marcela Guevara, Toral Gathani, Sabina Rinaldi, Paolo Vineis, Salvatore Vaccarella
{"title":"Education level and risk of breast cancer by tumor subtype in the EPIC cohort.","authors":"Margherita Pizzato, Valerie McCormack, Laure Dossus, Umaima Al-Alem, Cyrille Delpierre, Sebastien Lamy, Alessandra Macciotta, Fulvio Ricceri, Lene Mellemkjær, Anne Tjønneland, Christina C Dahm, Christian S Antoniussen, Pascal Guénel, Agnès Fournier, Pauline Frenoy, Matthias B Schulze, Rudolf Kaaks, Renée Turzanski Fortner, Pietro Ferrari, Valeria Pala, Salvatore Panico, Rosario Tumino, Giovanna Masala, Karina Standahl Olsen, Inger Torhild Gram, Tonje Braaten, Carlota Castro, Pilar Amiano Etxezarreta, Amaia Atxega, José María Huerta, Maria-José Sánchez, Marcela Guevara, Toral Gathani, Sabina Rinaldi, Paolo Vineis, Salvatore Vaccarella","doi":"10.1002/ijc.35413","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer (BC) is a heterogeneous disease with subtypes based on receptor status (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor 2 [HER2]), influencing prognosis and treatment. A higher socioeconomic position (SEP) is associated with an increased BC risk, but its relation to BC subtypes is less clear. This study analyzed 311,631 women from the EPIC cohort, focusing on the incidence of in situ and invasive BC (overall and by receptor status and subtype). Educational attainment was used as a proxy for SEP, and hazard ratios (HRs) were calculated using Cox regression models. Mediation analyses were performed to evaluate the extent to which selected risk factors explained the educational gradient. Over 14 years, 14,432 BC cases were identified, including 12,863 invasive cases. Lower education was associated with a reduced risk of both in situ and invasive BCs. The HRs for primary versus tertiary education were 0.61 (95% CI 0.49-0.73) for in situ and 0.81 (95% CI 0.75-0.87) for invasive BC overall, with similar reductions across ER-positive, PR-positive, HER2-positive, Luminal A, BH-, and BH+. No significant association was found between education and ER-negative, and HER2-enriched BCs. Reproductive and lifestyle factors explained 20-40% of the educational differences in BC risk. While many of the risk factors through which education impacts the development of subtype-specific BC were identified, others remain to be fully elucidated. Differences in screening attendance could partially explain the higher ER-positive BC risk among highly educated; this study further contributes to the understanding of the complex nature of BC in terms of its social gradient and aetiology.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.35413","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Breast cancer (BC) is a heterogeneous disease with subtypes based on receptor status (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor 2 [HER2]), influencing prognosis and treatment. A higher socioeconomic position (SEP) is associated with an increased BC risk, but its relation to BC subtypes is less clear. This study analyzed 311,631 women from the EPIC cohort, focusing on the incidence of in situ and invasive BC (overall and by receptor status and subtype). Educational attainment was used as a proxy for SEP, and hazard ratios (HRs) were calculated using Cox regression models. Mediation analyses were performed to evaluate the extent to which selected risk factors explained the educational gradient. Over 14 years, 14,432 BC cases were identified, including 12,863 invasive cases. Lower education was associated with a reduced risk of both in situ and invasive BCs. The HRs for primary versus tertiary education were 0.61 (95% CI 0.49-0.73) for in situ and 0.81 (95% CI 0.75-0.87) for invasive BC overall, with similar reductions across ER-positive, PR-positive, HER2-positive, Luminal A, BH-, and BH+. No significant association was found between education and ER-negative, and HER2-enriched BCs. Reproductive and lifestyle factors explained 20-40% of the educational differences in BC risk. While many of the risk factors through which education impacts the development of subtype-specific BC were identified, others remain to be fully elucidated. Differences in screening attendance could partially explain the higher ER-positive BC risk among highly educated; this study further contributes to the understanding of the complex nature of BC in terms of its social gradient and aetiology.
期刊介绍:
The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:
-Cancer Epidemiology-
Cancer Genetics and Epigenetics-
Infectious Causes of Cancer-
Innovative Tools and Methods-
Molecular Cancer Biology-
Tumor Immunology and Microenvironment-
Tumor Markers and Signatures-
Cancer Therapy and Prevention